Raffa Wealth Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Raffa Wealth Management's CYTK Position: Q3 2026 in Review
Raffa Wealth Management opened a new position in Cytokinetics (CYTK) in Q3 2026: 2 shares worth $132. The stake represents ﹤0.01% of the portfolio and ranks #1334 among its holdings.
473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Raffa Wealth Management held 2 shares of Cytokinetics worth $132 as of Q3 2026.
- Cytokinetics was a new Raffa Wealth Management position in Q3 2026.
- Cytokinetics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1334 holding.
- 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.